glucose, (beta-d)-isomer has been researched along with Non-ST-Elevation Myocardial Infarction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Budzianowski, J; Burchardt, P; Hiczkiewicz, J; Kasprzak, D; Musielak, B; Pieszko, K; Rzeźniczak, J; Winnicka-Zielińska, A | 1 |
1 other study(ies) available for glucose, (beta-d)-isomer and Non-ST-Elevation Myocardial Infarction
Article | Year |
---|---|
Beneficial effects of empagliflozin on hematocrit levels in a patient with severe anemia.
Topics: Aged; Anemia; Anticoagulants; Benzhydryl Compounds; Glucosides; Hematocrit; Humans; Male; Non-ST Elevated Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2021 |